More articles from Volume 43, Issue 4, 2014
OBIM DIFUZNOG OŠTEĆENJA NEURONSKIH I NENEURONSKIH STRUKTURA U KORELACIJI SA KOGNITIVNOM DISFUNKCIJOM
PREDIKTORI POBOLJŠANJA KVALITETA ŽIVOTA ŠEST MESECI NAKON HIRURŠKE REVASKULARIZACIJE MIOKARDA
LASEROTERAPIJA BOLA KOD AKUTNOG CERVIKALNOG SINDROMA
LOŠE ŽIVOTNE NAVIKE -FAKTORI RIZIKA ZA NASTANAK OSTEOPOROZE
Clinical, diagnostic and therapeutic aspects of pulmonary embolism
Clinical, diagnostic and therapeutic aspects of pulmonary embolism
,
Javorka Mitic
,
B. Mihailovic
,
Lj. Smilic
,
Z. Marcetic
,
S. Lazic
,
B. Bisevac
,
J. Jankovic
,
Lj. Stalevic
,
B. Odalovic
T. Smilic
Abstract
Pulmonary embolism (PE) and venous thromboembolism are two clinical manifestations of a single entity - venous thromboembolism. PE usually occurs through due thrombi from the lower veins, and in 10-15% of cases are due thrombus from upper veins or right heart failure. Significance is mainly determined by the frequency (1/1000 per year in the adult population; less in younger but significant increase with increasing age), the risk of mortality is important in acute and chronic diseases that are associated with this clinical manifestation. Acute pulmonary embolism is often fatal, with a mean annual mortality of about 30% in untreated. Many deaths occur because of recurrent PE within the first few hours after the initial event. In the nineteenth century, Virchow the mechanism of thromboembolism categorized into three groups: changes in the blood vessel wall, a reduction of blood flow (path) and changes in the composition of the blood (hypercoagulable, prothrombotic). Modern interpretation of the pathogenesis of thromboembolism, which is processed corresponds Virhovljevom concept. In general thromboembolic events can be a result of complications of individual risk factors as increased thrombotic potential.
Keywords
References
1.
Kt H, Manninodm, Leeper K. Pulmonary embolism mortality in the United States, 1978-1998; an analysis using multiple-cause mortality data. Arch Intern Med. 2003;1711.
2.
Dismuke S, Wagner E. Pulmonary embolism as a cause od death. The changig mortality in hospitalized patients. JAMA. 1986;2039.
3.
Dalen J, Alpert J. Natural history of pulmonary embolism. Prog Cardiovasc Dis. 1975;259.
4.
Anderson Fa W, Hb, Goldberg R. A population -based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Wercester DVT study. Arch Intern Med. 1991;933.
5.
Keley C, Duff M, A. The clinical course of pulmonary embolism. N Engl j Med. 1992;1240.
6.
Donaldson Ga WCS, Jg S, Rs. A reappraisal of the application of the Trendelenburg operation to massive fatal embolism. N Engl J Med. 1963;171.
7.
Rosendaal F. Venous thrombosis: a multicausal disease. Lancet. 1999;1167–73.
8.
Anderson D, Wells P. D-dimer for the diagnosis of venous thromboembolism. Cur Opin Hematol. 2000;296–301.
9.
Perrier A, Desmarais S, Miron M. Noninvasive diagnosis of venous thromboembolism in outpatients. Lancet. 1999;190–5.
10.
Grot D, Van Marwijik Kooy M, Pouwels M, Engelage J, Kupers A, Buller B, et al. The use of a rapid D-dimer blood test in the diagnosis work-up for pulmonary embolism: a management study. Thromb Haemost. 1999;1588–92.
11.
Wolde T, Hagen M, Macgillavry P, M. Noninvasive diagnostic work-up of patients with suspected pulmonary embolism; preliminary results of a menagement study. Thromb Haemost. 2001;153.
12.
Gottschalk A, Sostman H, Coleman R. Ventilation-perfusion scintigraphy in the PIOPED study.Part II. Evaluation of the scintigraphic criteria and interpretations. J Nucl Med. 1993;1119–26.
13.
Sostman H, Coleman R, Long D, Newman D, Paine G, S. Evaluation of revised criteria for ventilation-perfusion scintigraphy in patients with suspected pulmonary embolism. Radiology. 1994;103–7.
14.
Stein P, Gottschalk A. Critical review of ventilation/perfusion lung scans in acute pulmonary embolism. Prog Cardiovasc Dis. 1994;13–24.
15.
Freeman L, Krynyckyi B, Zuckier L. Enhanced lung scan diagnosis of pulmonary embolism with the use of ancillary scintigraphic findings and clinical correlation. Semin Nucl Med. 2001;143–57.
16.
Corubs H, Seitz J, Larson R. Diagnostic usefulnes of lung SPECT in pulmonary thromboembolism: an otcome study. Nucl Med commun. 1997;(18):897–906.
17.
Monreal M, Ruiz J, Fraile M. Prospective study on the usefulness of lungscan in patients with deep vein thrombosis of the lower limbs. Thromb Haemost. 2001;771–4.
18.
Remy-Jardin M, Remij. Spiral CT angiography of the pulmonary circulation. Radiology. 1999;615–36.
19.
Jime̓ Nez D, Lobo J, Monreal M, Remedio R, Otero R, Yusen R. Prognostic significance of multidetector computed tomography in normotensive patients with pulmonary embolism: rationale, methodology and reproducibility for the PROTECT study. Journal of Thrombosis and Thrombolysis. (2):187–92.
20.
Jime̓ Nez D. Prognostic significance of multidetector CT in normotensive patients with pulmonary embolism: results of the protect study. Thorax.
21.
Pruszzcyk P, Torbicki A, Kuch-Wocial, Szulc M, Pacho R. Diagnostic value of transoesophageal echocardiography in suspected haemodinamically significant pulmonary embolism. Heart. 2001;628–34.
22.
Pruszzcyk P, Torbicki A, Pacho R. Noninvasive diagnosis of suspected severe pulmonary embolism: transoesophageal echocardiography versus spiral CT. Chest. 1997;722–8.
23.
Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfe L. Echocardiography doppler in pulmonary embolism. Right ventricular dysfunction as a predictor of mortality rate. American haert J. 1997;479–84.
24.
Grifoni S, Olivotto I, Cecchini P, Pieralli F, Camiti A. Short-term clinical outcome of patients with acute pulmonary embolism, normal blood pressure, and echocardiographic right ventricular dysfuntion. Circulation. 2000;2817–22.
25.
Van Beek E, Bakker A, Reekers J. Pulmonary embolism. Interobserver agreement in the interpretation of conventional angiographic and DSA images in patients with non-diagnostic lung scan results. Radiology. 1996;721–4.
26.
Novelline R, Baltarowich O, Athanasoulis C, Waltman A, Greenfield A, Mckusick K. The clinical course of patients with suspected pulmonary embolism and a negative pulmonary arteriogram. Radiology. 1978;561–7.
27.
Cheely R, Mccartney W, Perry J. The role of non-invasive tests versus pulmonary angiography in the diagnosis of pulmonary embolism. Am j Med. 1981;17–22.
28.
Hull R, Hirsh J, Carter C. Pulmonary angiography, ventilation lung scanning and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan. Ann Intern Med. 1983;891–9.
29.
Henry J, Relyea B, Stein P. Continuing risk of thromboembolism among patients with normal pulmonary angiograms. Chest. 1995;1375–8.
30.
Van Beek E, Reekers J, Batchelor D, Brandjes D, Buller H. Feasibility, safety and clinical utility of angiography in suspected pulmonary embolism. Eur radiology. 1996;415–9.
31.
Malinovski N, Kozlov V. A: Antikoagulantna i trobolitička terapija u hirurgiji. Medicina" Moskva. 1976;
32.
Torbicki A, Perrier A, Konstantinides S, Agnelli G, Igalie N, Pruszczyk P, et al. Guidelines of the diagnosis and menagement of Acute Pulmonary Embolism of the. Eur Heart J. 2008;2276–81.
33.
Scanchel O, Trinquart L, Colombet I, Durieux P, Huisman M, Chatellier E, et al. Prognostic value of right ventricular dysfunction on patient with haemodinamically stable pulmonary embolism: a systematic review. Eur Heart J. 2008;1569–72.
34.
Wicki J, Perrier A, Perneger T, Bounameaux H, Jound A. Predicting adverse out come in patients with acute pulmonary embolism: a risk score. Thromb Haemost. 2000;548–52.
35.
Aujesky D, Obrosky D, Stone R, Duble T, Perrica A, Cornul J, et al. Derivation and validation of prognostic model for pulmonary embolism. Am J Respir Crit care med. 2005;1041–6.
36.
Aujesky D, Roy P, Manach L, Verschuren C, Meyer F, Obrosky G, et al. Validation of a model to predict adverse outcomes in patiens with pulmonary embolism Eur. Heart J. 2006;476–81.
37.
Aujesky D, Perrier A, Roy P, Stone R, Cornuz J, Meyer G, et al. Validation of a clinical prognostic model to identifity low risk patients with pulmonary embolism. J Intern Med. 2007;597–604.
38.
Jimenez D, Yusen R, Otero R, Otero R, Uresandi F, Mauffal D, et al. Prognostic models for seleccting patients with acute pulmonary embolism for initial out patient therapy chest. 2007;24–30.
39.
Choi K. Prognostic implications of computed tomographic right ventricular dilation in patients with acute pulmonary embolism Thromb Res. 2013;
40.
Vanni S. Comparison of two prognostic models for acute pulmonary embolism; clinical vs. Right ventricular dysfunctionguided approach. J Thromb Haemost. 2011;(9):1916.
41.
Tapson V. Acute pulmonary embolism. N Engl J Med. 2008;1037.
42.
Goldhaber S, Visani L, Rosa D, M. Acute pulmonary embolism: clinical outcomes in the international Cooperative pulmonary Embolism registry (COOPER). Lancet. 1999;1386.
43.
Kearon C, Akl E, Aj C. Antithrombotic therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicans Evidence-Based Clinical PracticeGuideines. Chest. 2012;419.
44.
Hyers T, Hull R, Weg J. Antithrombotic therapy for venous thromboembolic disease. Chest. 1992;(4):408.
45.
Wheeler A, Jaquiss R, Newman J. Physician practices in the tretatment of pulmonary embolism and deep venous thrombosis. Arch Int Med. 1988;1321–6.
46.
Tapsonvf. Acute pulmonary embolism. N Engl J Med. 2008;358–1037.
47.
Goldhaber S. Evolving concept in thrombolytic therapy for pulmonary embolism. Chest. 1992;(Suppl 4):183.
48.
Bookstein J, Fellmeth B, Roberts A. Pulse-spray pharmacomechanical thrombolysis: preliminary clinical results. Am Roentgenol. 1989;671–92.
49.
Wolfe M, Skibo L, Goldhaber S. Pulmonary embolic disease: diagnose, pathophysiologic aspect and treatment with thrombolytic therapy. Curr Prob Card. 1933;585–561.
50.
Goldhaber S, Haire W, Feldstein M. Ateplase versus heparin in acute pulmonary embolism randomised trial assessing right ventricular function and pulmonary perfusion. Lancet. 1993;507–11.
51.
Greenfield I, Michna B. Twelve-year clinical expirience with the Greenfield vena cava filter. Surgery. 1988;706–12.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
